Hypertension Diagnostics Stock Z Score
Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Hypertension |
Hypertension Diagnostics Company Z Score Analysis
Hypertension Diagnostics' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Hypertension Diagnostics Z Score | -31.6 |
Most of Hypertension Diagnostics' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hypertension Diagnostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionAccording to the company's disclosures, Hypertension Diagnostics has a Z Score of -31.6. This is 1411.2% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The z score for all United States stocks is notably higher than that of the company.
Hypertension Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hypertension Diagnostics' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Hypertension Diagnostics could also be used in its relative valuation, which is a method of valuing Hypertension Diagnostics by comparing valuation metrics of similar companies.Hypertension Diagnostics is currently under evaluation in z score category among its peers.
Hypertension Fundamentals
Return On Asset | 3.0E-4 | ||||
Profit Margin | (0.03) % | ||||
Operating Margin | 0.0002 % | ||||
Current Valuation | 5.26 M | ||||
Shares Outstanding | 52.39 M | ||||
Price To Earning | (0.03) X | ||||
Price To Sales | 0.15 X | ||||
Revenue | 3.79 M | ||||
Gross Profit | 954.47 K | ||||
EBITDA | 72.29 K | ||||
Net Income | (125.39 K) | ||||
Cash And Equivalents | 5.66 K | ||||
Total Debt | 4.69 M | ||||
Current Ratio | 0.52 X | ||||
Book Value Per Share | (0.09) X | ||||
Cash Flow From Operations | (389.28 K) | ||||
Earnings Per Share | (0) X | ||||
Beta | -0.92 | ||||
Market Capitalization | 730.42 K | ||||
Total Asset | 1.28 M | ||||
Retained Earnings | (30.68 M) | ||||
Working Capital | (857 K) | ||||
Current Asset | 277 K | ||||
Current Liabilities | 1.13 M | ||||
Z Score | -31.6 | ||||
Net Asset | 1.28 M |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Hypertension Pink Sheet
If you are still planning to invest in Hypertension Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hypertension Diagnostics' history and understand the potential risks before investing.
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |